{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:03:49Z","timestamp":1790845429808,"version":"4.1.0"},"reference-count":84,"publisher":"FapUNIFESP (SciELO)","issue":"1 suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"DOI":"10.1590\/0001-3765201820170830","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T18:41:43Z","timestamp":1528310503000},"page":"1251-1271","source":"Crossref","is-referenced-by-count":75,"title":["Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives"],"prefix":"10.1590","volume":"90","author":[{"given":"LUIZ C.S.","family":"PINHEIRO","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00cdVIA M.","family":"FEITOSA","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brazil; Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FL\u00c1VIA F. DA","family":"SILVEIRA","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brazil; Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NUBIA","family":"BOECHAT","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"ACHAN J","year":"2011","journal-title":"Malar J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ddr.20346","article-title":"Artesunate plus amodiaquine combination therapy: reviewing the evidence","volume":"71","author":"ADJEI GO","year":"2010","journal-title":"Drug Dev Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1475-2875-11-316","article-title":"The global pipeline of new medicines for the control and elimination of malaria","volume":"11","author":"ANTHONY MP","year":"2012","journal-title":"Malaria"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bmcl.2009.02.013","article-title":"Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates","volume":"19","author":"ARAUJO NCP","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","article-title":"Antimalarials in Development in 2014","volume":"114","author":"BARNETT DS","year":"2014","journal-title":"Chem Rev"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007871","article-title":"Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial","volume":"4","author":"BASSAT Q","year":"2009","journal-title":"PLoS ONE"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","article-title":"Recent advances in malaria drug discovery","volume":"23","author":"BIAMONTE MA","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref8","series-title":"Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine","author":"BOECHAT N","year":"2014"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmcl.2009.04.100","article-title":"Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: Design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition","volume":"19","author":"CAPELA R","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy","volume":"55","author":"CAPELA R","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","year":"2017"},{"key":"ref12","series-title":"Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry","first-page":"313","volume-title":"Sesquiterpene lactones: structural diversity and their biological activities","author":"CHATURVEDI D","year":"2011"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"CHATURVEDI D","year":"2010","journal-title":"Chem Soc Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.bmc.2012.06.014","article-title":"Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin","volume":"20","author":"CLOETE TT","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejmech.2014.01.040","article-title":"Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisininetriazine hybrids and hybrid-dimers","volume":"76","author":"CLOETE TT","year":"2014","journal-title":"Eur J Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bmcl.2014.01.059","article-title":"The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether","volume":"24","author":"CONYERS RC","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bmcl.2014.11.064","article-title":"Antimalarial chemotherapy: Orally curative artemisinin-derived trioxane dimer esters","volume":"25","author":"CONYERS RC","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1475-2875-11-270","article-title":"Review of pyronaridine anti-malarial properties and product characteristics","volume":"11","author":"CROFT SL","year":"2012","journal-title":"Malar J"},{"key":"ref19","first-page":"49","article-title":"F\u00e1rmacos antimalariais - hist\u00f3ria e perspectivas","volume":"89","author":"CUNICO W","year":"2008","journal-title":"Rev Bras Farm"},{"key":"ref20","series-title":"Science Medicine Health","year":"2017"},{"key":"ref21","series-title":"Science Medicine Health. Eurartesim (dihydroartemisinin\/ piperaquine) 20 mg\/160 mg and 40 mg\/320 mg film-coated tablets: EU summary of product characteristics","year":"2017"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2011.04.018","article-title":"Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on b-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum","volume":"82","author":"FENG TS","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1590\/S0100-40422008000500060","article-title":"Mal\u00e1ria: aspectos hist\u00f3ricos e quimioterapia","volume":"31","author":"FRAN\u00c7A TCC","year":"2008","journal-title":"Quim Nova"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cll.2009.10.001","article-title":"Malaria","volume":"30","author":"GARCIA LS","year":"2010","journal-title":"Clin Lab Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phytochem.2014.08.004","article-title":"In vitro antimalarial studies of novel artemisinin biotransformed products and its derivatives","volume":"107","author":"GAUR R","year":"2014","journal-title":"Phytochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200140050-00003","article-title":"Pharmacokinetic interactions of antimalarial agents","volume":"40","author":"GIAO PT","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/156802606776743129","article-title":"From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements","volume":"6","author":"HAYNES RK","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"KAUR K","year":"2010","journal-title":"Eur J Med Chem"},{"key":"ref29","series-title":"Treatment and Prevention of Malaria","first-page":"157","volume-title":"Artemisinins: Artemisinin, Dihydroartemisinin, Artemether and Artesunate","author":"KARUNAJEEWA HA","year":"2012"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/11203910-000000000-00000","article-title":"Dihydroartemisinin\/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria","volume":"72","author":"KEATING GM","year":"2012","journal-title":"Drugs"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-012-2886-x","article-title":"From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy","volume":"111","author":"KRAFTS K","year":"2012","journal-title":"Parasitol Res"},{"key":"ref32","first-page":"59","article-title":"Malaria: from old drugs to new molecular targets","volume":"2","author":"LEITE FHA","year":"2013","journal-title":"Biochem Biotechnol Rep"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/molecules15031378","article-title":"Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies","volume":"15","author":"LI J","year":"2010","journal-title":"Molecules"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1475-2875-12-71","article-title":"Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids","volume":"12","author":"LOMBARD MC","year":"2013","journal-title":"Malar J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","article-title":"Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids","volume":"21","author":"LOMBARD MC","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4269\/ajtmh.13-0283","article-title":"Pharmacokinetics of artesunate alone and in combination with sulfadoxine\/pyrimethamine in healthy Sudanese volunteers","volume":"90","author":"MATAR KM","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.bmcl.2014.04.025","article-title":"Antimalarial chemotherapy: Artemisinin-derived dimer carbonates and thiocarbonates","volume":"24","author":"MAZZONE JR","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid Molecules with a Dual Mode of Action: Dream or Reality","volume":"41","author":"MEUNIER B","year":"2008","journal-title":"Accounts Chem Res"},{"key":"ref39","first-page":"231","article-title":"Drug-resistant malaria in South Asian countries: a review of evidence and future prospects of nanomedicine based strategies for prophylaxis and treatment","volume":"2","author":"MIDHA K","year":"2015","journal-title":"EJPMR"},{"key":"ref40","series-title":"Extraction of Artemisinin, an Active Antimalarial Phytopharmaceutical from Dried Leaves of Artemisia annua L., Using Microwaves and a Validated HPTLC-Visible Method for Its Quantitative Determination","author":"MISRA H","year":"2014"},{"key":"ref41","year":"2017"},{"key":"ref42","year":"2017"},{"key":"ref43","year":"2017"},{"key":"ref44","year":"2017"},{"key":"ref45","year":"2017"},{"key":"ref46","year":"2017"},{"key":"ref47","year":"2017"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed Multiple Ligands. An Emerging Drug Discovery Paradigm","volume":"48","author":"MORPHY R","year":"2005","journal-title":"J Med Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"MUREGI FW","year":"2010","journal-title":"Drug Dev Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2009.00709.x","article-title":"Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development","volume":"23","author":"NA-BANGCHANG K","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-009-0656-1","article-title":"Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers","volume":"65","author":"NAVARATNAM V","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/AAC.01717-08","article-title":"Pharmacokinetics and ex vivo pharmacodynamics antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam","volume":"53","author":"NGUYEN DVH","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref53","series-title":"Treatment and Prevention of Malaria. Antimalarial Drug Chemistry, Action and Use","first-page":"95","volume-title":"Other 4-Methanolquinolines, Amyl Alcohols and Phentathrenes: Mefloquine, Lumefantrine and Halofantrine","author":"NOSTEN F","year":"2012"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.clpt.6100361","article-title":"Pharmacologic advances in the global control and treatment of malaria: Combination therapy and resistance","volume":"82","author":"NYUNT MM","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref55","series-title":"Treatment and Prevention of Malaria. Antimalarial Drug Chemistry, Action and Use","first-page":"113","volume-title":"Antifolates: Pyrimethamine, Proguanil, Sulphadoxine and Dapsone","author":"NZILA A","year":"2012"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The Molecular Mechanism of Action of Artemisinin-The Debate Continues","volume":"15","author":"O\u2019NEILL PM","year":"2010","journal-title":"Molecules"},{"key":"ref57","series-title":"Treatment and Prevention of Malaria. Antimalarial Drug Chemistry, Action and Use","first-page":"19","volume-title":"4-Aminoquinolines: Chloroquine, Amodiaquine and Next-Generation Analogues","author":"O\u2019NEILL PM","year":"2012"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2875-7-125","article-title":"Reduction of transmission from malaria patients by artemisinin combination therapies: A pooled analysis of six randomized trials","volume":"7","author":"OKELL LC","year":"2008","journal-title":"Malar J"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/jm058288w","article-title":"Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity","volume":"49","author":"PAIK IH","year":"2006","journal-title":"J Med Chem"},{"key":"ref60","first-page":"430","article-title":"Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy","volume":"45","author":"PALMER KJ","year":"1993","journal-title":"Drugs"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2017.09.040","article-title":"Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolanepolyamine conjugates","volume":"40","author":"PEARCE AN","year":"2017","journal-title":"Eur J Med Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/AAC.02216-15","article-title":"Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine","volume":"60","author":"PENNA-COUTINHO J","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1254417","article-title":"Antibodies to PfSWA-1 block parasite egress from RBCs and protect against malaria infection","volume":"344","author":"RAJ DK","journal-title":"Science"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10124","article-title":"A 2020 vision for vaccines against HIV, tuberculosis and malaria","volume":"473","author":"RAPPUOLI R","year":"2011","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"REITER C","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"REITER C","year":"2015","journal-title":"Eur J Med Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ardp.200700184","article-title":"Antimalarial Drugs - What is in Use and What is in the Pipeline","volume":"341","author":"SCHLITZER M","year":"2008","journal-title":"Arch Pharm Chem Life Sci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijmm.2012.07.009","article-title":"The antimalarial pipeline - An update","volume":"302","author":"SCHRADER FC","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"SEDER RA","year":"2013","journal-title":"Science"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","article-title":"Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial","volume":"16","author":"SIRIMA SB","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2014.11.016","article-title":"Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters","volume":"90","author":"SMIT FJ","year":"2015","journal-title":"Eur J Med Chem"},{"key":"ref72","series-title":"Treatment and Prevention of Malaria. Antimalarial Drug Chemistry, Action and Use","first-page":"19","author":"STAINES HM","year":"2012"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1021\/cr500123g","article-title":"\u201cRecycling\u201d Classical Drugs for Malaria","volume":"114","author":"TEIXEIRA C","year":"2014","journal-title":"Chem Rev"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QCO.0b013e328010b848","article-title":"8-Aminoquinolines: future role as antiprotozoal drugs","volume":"19","author":"TEKWANI BL","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"ref75","series-title":"The Nobel Prize in Physiology or Medicine 2015","author":"THE NOBEL FOUNDATION","year":"2015"},{"key":"ref76","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/73589846-034d-4b6f-9668-54f278fa03e8","article-title":"An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia","volume":"5","author":"VALECHA N","year":"2010","journal-title":"PLoS One"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"VANDEKERCKHOVE S","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/AAC.00510-08","article-title":"Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate","volume":"52","author":"VAROTTI FP","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A novel artemisinin-quinine hybrid with potent antimalarial activity","volume":"17","author":"WALSH JJ","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref80","series-title":"Treatment and Prevention of Malaria. Antimalarial Drug Chemistry, Action and Use","first-page":"69","author":"WATERS NC","year":"2012"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-12-68","article-title":"The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study","volume":"12","author":"WELLS S","year":"2013","journal-title":"Malar J"},{"key":"ref82","series-title":"Guidelines for the Treatment of Malaria","year":"2015","edition":"3rd"},{"key":"ref83","series-title":"World Malaria Report","year":"2016"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/molecules15020804","article-title":"Ancient chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity","volume":"15","author":"WRIGHT CW","year":"2010","journal-title":"Molecules"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v90n1s2\/0001-3765-aabc-90-01-s2-01251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:34:33Z","timestamp":1720344873000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652018000301251&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":84,"journal-issue":{"issue":"1 suppl 2","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0001-37652018000301251"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765201820170830","relation":{},"ISSN":["1678-2690","0001-3765"],"issn-type":[{"value":"1678-2690","type":"electronic"},{"value":"0001-3765","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}